Discover Tenders by Pharmaceutical Products Sector

Find the most relevant tenders for Pharmaceutical Products. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Pharmaceutical Products tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Pharmaceutical Products tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Medicines With The Active Ingredient Testosterone Atc G03Ba03 In The Dosage Form Injection Solution

Deadline: 30 Apr 2026

Germany

Ref. No.: 5762364

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Nga Boosting Innovative Geoint Science Technology Broad Agency Announcement Big St Baa

Deadline: 14 Dec 2026

United States

Ref. No.: 5760635

EMD:Ref Document

Bid Value: Ref Document

406 Days Left

Dps For Skills And Investment Grant Funding

Deadline: 30 Sep 2028

Great Britain

Ref. No.: 5750837

EMD:Ref Document

Bid Value: Ref Document

1062 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Aclidinium Bromide Atc Code According To Who R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 5727483

EMD:Ref Document

Bid Value: Ref Document

117 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole A02Bd08 As Part Of A So Called Open Hou

Deadline: 30 Apr 2026

Germany

Ref. No.: 5723430

EMD:Ref Document

Bid Value: Ref Document

178 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5720077

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5719969

EMD:Ref Document

Bid Value: Ref Document

189 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5719627

EMD:Ref Document

Bid Value: Ref Document

189 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5719561

EMD:Ref Document

Bid Value: Ref Document

188 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5718497

EMD:Ref Document

Bid Value: Ref Document

189 Days Left

Showing 55201 to 55215 of 55722 results

‹
1
2
...
3678
3679
3680
3681
3682
3683
3684
...
3714
3715
›

Discover Tenders by Pharmaceutical Products Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Products Sector

Filter Your Search

FREE Trial plan for all new users!